216 related articles for article (PubMed ID: 7512798)
1. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
2. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
5. Desmoplastic cellular blue nevi.
Michal M; Kerekes Z; Kinkor Z; Ondriás F; Pizinger K
Am J Dermatopathol; 1995 Jun; 17(3):230-5. PubMed ID: 8599430
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of malignant melanoma.
Hirano T
Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
9. Psammomatous malignant melanoma arising in an intradermal naevus.
Monteagudo C; Ferrández A; González-Devesa M; Llombart-Bosch A
Histopathology; 2001 Nov; 39(5):493-7. PubMed ID: 11737307
[TBL] [Abstract][Full Text] [Related]
10. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Kontochristopoulos GJ; Stavropoulos PG; Krasagakis K; Goerdt S; Zouboulis CC
Dermatology; 2000; 201(2):123-6. PubMed ID: 11053914
[TBL] [Abstract][Full Text] [Related]
12. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.
Longacre TA; Egbert BM; Rouse RV
Am J Surg Pathol; 1996 Dec; 20(12):1489-500. PubMed ID: 8944042
[TBL] [Abstract][Full Text] [Related]
13. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
Boyle JL; Haupt HM; Stern JB; Multhaupt HA
Arch Pathol Lab Med; 2002 Jul; 126(7):816-22. PubMed ID: 12088451
[TBL] [Abstract][Full Text] [Related]
16. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
Hitchcock MG; McCalmont TH; White WL
Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemistry of neurotropic melanoma.
Warner TF; Lloyd RV; Hafez GR; Angevine JM
Cancer; 1984 Jan; 53(2):254-7. PubMed ID: 6360335
[TBL] [Abstract][Full Text] [Related]
19. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
[TBL] [Abstract][Full Text] [Related]
20. Granular cell change in smooth muscle tumours of skin and soft tissue.
Mentzel T; Wadden C; Fletcher CD
Histopathology; 1994 Mar; 24(3):223-31. PubMed ID: 8200624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]